Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

Bulky and residual tumor are considered to increase the risk of relapse in diffuse large B‐cell lymphoma (DLBCL) patients. Radiotherapy is conventionally used to reduce the risk, but the evidence is controversial. We performed a retrospective analysis to evaluate the significance of bulky and residu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokola, Susanna, Kuitunen, Hanne, Turpeenniemi‐Hujanen, Taina, Kuittinen, Outi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064117/
https://www.ncbi.nlm.nih.gov/pubmed/31967739
http://dx.doi.org/10.1002/cam4.2798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064117/
https://www.ncbi.nlm.nih.gov/pubmed/31967739
http://dx.doi.org/10.1002/cam4.2798

Ejemplares similares